Articles dans des revues avec comité de lecture (367)
  1. 106. Kenis, C., Bron, D., Libert, Y., Decoster, L., Van Puyvelde, K., Scalliet, P., Cornette, P., Pepersack, T., Luce, S., Langenaeken, C., Rasschaert, M., Allepaerts, S., van Rijswijk, R., Milisen, K., Flamaing, J., Lobelle, J. P., & Wildiers, H. (2013). Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Annals of oncology, 24(5), 1306-1312. doi:10.1093/annonc/mds619
  2. 107. Najar, M., Raicevic, G., Fayyad Kazan, H., De Bruyn, C., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2013). Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration. International immunopharmacology, 15(4), 693-702. doi:10.1016/j.intimp.2013.02.020
  3. 108. Azerad, M.-A., Debaugnies, F., Demulder, A., Bron, D., & Efira, A. (2013). Microvesicles and cancer. Belgian Journal of Hematology, 4(1), 3-8.
  4. 109. Andre, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Pieters, K., Bron, D., & Lagneaux, L. (2013). Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells. PloS one, 8(3), e59756. doi:10.1371/journal.pone.0059756
  5. 110. Ribrag, V., Tilly, H., Casasnovas, O., Bosly, A., Bouabdallah, R., Delarue, R., Boue, F., Bron, D., Feugier, P., Haioun, C., Offner, F., & Coiffier, B. (2013). Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). European journal of cancer, 49(4), 904-910. doi:10.1016/j.ejca.2012.11.015
  6. 111. Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., Bron, D., & Englert, Y. (2013). Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. Journal of clinical oncology, 31(7), 903-909. doi:10.1200/JCO.2012.42.8185
  7. 112. Bosly, A., Grigg, A., Holte, H., Gisselbrecht, C., Radford, J., Rossi, A., Lopez-Guillermo, A., Trneny, M., Sebban, C., Hagberg, H., da Costa, F. L., Colombat, P., Bron, D., & Coiffier, B. (2013). A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma. The oncologist, 18(11), 1189. doi:10.1634/theoncologist.2013-0223
  8. 113. Verhoef, G., Schroyens, W., Bron, D., Bonnet, C., De Wilde, V., Van Hoof, A., Janssens, A., Dierickx, D., Andre, M., & Vandenneste, E. (2013). Guidelines newly diagnosed diffuse B-large cell lymphoma (DLBCL) and relapsed DLBCL. Belgian Journal of Hematology, 4(2), 51-57.
  9. 114. Roos-Weil, D., Dietrich, S., Dreger, P., Boumendil, A., Polge, E., Bron, D., Carreras, E., Atienza, A. I., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., & Mohty, M. (2013). Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: A retrospective study from the European Group for Blood and Marrow Transplantation. Blood, 121(3), 440-446. doi:10.1182/blood-2012-08-448613
  10. 115. Najar, M., Raicevic, G., De Bruyn, C., Bron, D., Toungouz Nevessignsky, M., Lagneaux, L., & Fayyad Kazan, H. (2012). Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming(Stem Cell Rev and Rep, 10.1007/s12015-012-9408-1). Stem cell reviews, 8(4), 1286. doi:10.1007/s12015-012-9415-2
  11. 116. Najar, M., Raicevic, G., Fayyad Kazan, H., Kazan, H. F., De Bruyn, C., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2012). Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem cell reviews, 8(4), 1188-1198. doi:10.1007/s12015-012-9408-1
  12. 117. Van Damme, M., Crompot, E., Meuleman, N., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2012). HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance. Epigenetics, 7(12), 1403-1412. doi:10.4161/epi.22674
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>